Information for Patients & Caregivers

Systemic Lupus Erythematosus

Approved to treat lupus flare or to be used as maintenance therapy.

Multiple Sclerosis Relapse

An alternative for speeding the relief of relapse in adults.

Proteinuria in Nephrotic Syndrome

Treatment for too much protein in your urine.

Infantile Spasms

Treat your child’s condition with an FDA-approved treatment for infantile spasms.

Dermatomyositis and Polymyositis

An FDA-approved treatment for systemic dermatomyositis and polymyositis.

Symptoms of Sarcoidosis

Treat your symptoms of sarcoidosis with an FDA-approved medication.

Rheumatoid Arthritis

FDA approved as a short-term, add-on treatment for recurring symptoms or as maintenance therapy.

Ophthalmic Conditions

A treatment of severe acute and chronic allergic and inflammatory conditions affecting different parts of the eye.

Psoriatic Arthritis

An FDA-approved, short-term treatment to help manage psoriatic arthritis (PsA) flares.

H.P. Acthar® Gel (repository corticotropin injection) is used for:

  • Treatment for flares or on a regular basis (maintenance) in people with systemic lupus erythematosus (lupus)
  • Treatment of infantile spasms in infants and children under 2 years of age
  • Treatment for adults with acute relapses or flares of multiple sclerosis (MS). Studies have shown H.P. Acthar Gel to be effective in speeding recovery from an MS relapse. However, there is no evidence that Acthar affects the ultimate outcome or natural history of the disease
  • The reduction of proteinuria in people with nephrotic syndrome of the idiopathic type (unknown origin) without uremia (accumulation of urea in the blood due to malfunctioning kidneys) or that due to lupus erythematosus (lupus)
  • Treatment for flares or on a regular basis (maintenance) in people with systemic dermatomyositis or polymyositis (DM-PM)
  • Treatment for people with symptoms of sarcoidosis
  • Short-term add-on therapy in the event of symptoms suddenly worsening (flare) for psoriatic arthritis, rheumatoid arthritis, juvenile rheumatoid arthritis (in some cases, may require low-dose maintenance therapy), and ankylosing spondylitis (fusion of the spinal vertebrae)
  • Treatment of severe acute and chronic allergic and inflammatory conditions affecting different parts of the eye. This can include the front part of the eye such as the cornea and iris, or the back part of the eye such as the optic nerve and retina
  • Short-term add-on therapy in the event of symptoms suddenly worsening (flare) for psoriatic arthritis
  • Add-on treatment for recurring symptoms, or on a regular basis, in people with rheumatoid arthritis (RA)

IMPORTANT SAFETY INFORMATION

SEE More

Who should  NOT take Acthar?

You should not take Acthar if you have: